Zhejiang Jingxin Pharmaceutical Co., Ltd.

SZSE:002020 Stock Report

Market Cap: CN¥10.7b

Zhejiang Jingxin Pharmaceutical Future Growth

Future criteria checks 1/6

Zhejiang Jingxin Pharmaceutical is forecast to grow earnings and revenue by 14.4% and 13.3% per annum respectively. EPS is expected to grow by 14.2% per annum. Return on equity is forecast to be 13.3% in 3 years.

Key information

14.4%

Earnings growth rate

14.2%

EPS growth rate

Pharmaceuticals earnings growth18.7%
Revenue growth rate13.3%
Future return on equity13.3%
Analyst coverage

Low

Last updated08 Nov 2024

Recent future growth updates

No updates

Recent updates

We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt

Oct 04
We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt

Zhejiang Jingxin Pharmaceutical Co., Ltd.'s (SZSE:002020) Low P/E No Reason For Excitement

Sep 12
Zhejiang Jingxin Pharmaceutical Co., Ltd.'s (SZSE:002020) Low P/E No Reason For Excitement

Zhejiang Jingxin Pharmaceutical (SZSE:002020) Has Announced A Dividend Of CN¥0.30

May 21
Zhejiang Jingxin Pharmaceutical (SZSE:002020) Has Announced A Dividend Of CN¥0.30

Zhejiang Jingxin Pharmaceutical's (SZSE:002020) Problems Go Beyond Weak Profit

Apr 08
Zhejiang Jingxin Pharmaceutical's (SZSE:002020) Problems Go Beyond Weak Profit

We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt

Mar 29
We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt

Earnings and Revenue Growth Forecasts

SZSE:002020 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20265,7409639781,2085
12/31/20255,0118016591,0475
12/31/20244,422693N/A8495
9/30/20244,282721647905N/A
6/30/20244,212705546856N/A
3/31/20244,099639608947N/A
12/31/20233,999619273793N/A
9/30/20233,905663205675N/A
6/30/20233,844681534995N/A
3/31/20233,870676463885N/A
1/1/20233,780662340856N/A
9/30/20223,705645192914N/A
6/30/20223,613630-127580N/A
3/31/20223,480616-252463N/A
1/1/20223,467613-33373N/A
9/30/20213,384720-127176N/A
6/30/20213,3447089377N/A
3/31/20213,322691131471N/A
12/31/20203,258653179513N/A
9/30/20203,287404213598N/A
6/30/20203,42942085424N/A
3/31/20203,547485247588N/A
12/31/20193,647520198535N/A
9/30/20193,507517433686N/A
6/30/20193,394482482675N/A
3/31/20193,194413283542N/A
12/31/20182,944369270523N/A
9/30/20182,906356317510N/A
6/30/20182,629307N/A381N/A
3/31/20182,384279N/A346N/A
12/31/20172,219264N/A385N/A
9/30/20172,071248N/A141N/A
6/30/20171,982231N/A339N/A
3/31/20171,936213N/A233N/A
12/31/20161,875200N/A253N/A
9/30/20161,735222N/A259N/A
6/30/20161,613209N/A168N/A
3/31/20161,502186N/A158N/A
12/31/20151,416166N/A145N/A
9/30/20151,362158N/A168N/A
6/30/20151,335143N/A169N/A
3/31/20151,294123N/A230N/A
12/31/20141,235107N/A210N/A
9/30/20141,183102N/A190N/A
6/30/20141,11290N/A175N/A
3/31/20141,03175N/A175N/A
12/31/201397464N/A111N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 002020's forecast earnings growth (14.4% per year) is above the savings rate (2.8%).

Earnings vs Market: 002020's earnings (14.4% per year) are forecast to grow slower than the CN market (26.1% per year).

High Growth Earnings: 002020's earnings are forecast to grow, but not significantly.

Revenue vs Market: 002020's revenue (13.3% per year) is forecast to grow slower than the CN market (13.8% per year).

High Growth Revenue: 002020's revenue (13.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 002020's Return on Equity is forecast to be low in 3 years time (13.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y